International Congress on Vaccines & Immunology December 06-07, 2018
Hotel Hyatt Place Amsterdam Airport, Netherlands

Track 1: Vaccines

Vaccination is more important in our life for keeping us healthy. It helps us to fight against many chronic diseases like small pox, measles, Influenza, etc. The eradication of small pox is highly achieved by the vaccine discovery. A vaccine contains a disease causing microorganism like bacteria and viruses. The agents present in the vaccine when vaccinated stimulate the immune system and it gets recognized and the body’s immune system eliminates the infection. But vaccines remain elusive for the treatment of many important diseases like Herpes, Malaria, Ebola, HIV, etc. This Conference brings out the knowledge about the recent research and future aspects of Vaccines.

Track 2: Immunology

The main function of the immune system is to fight against the antigens that enter in to the body. It also can recognize the self and non-self-antigens. Immunology also deals with the immunological disorders like graft rejection, hypersensitivities; autoimmune diseases. It contains the branches like innate and adaptive immunities. The adaptive immune system mediates the cell mediated and humoral immune responses.  The research and development in immunology also now targeted on the animals and new therapeutics were invented against the diseases that were infecting the animals. The immunoglobulin molecules play an important role in immune system by neutralizing the antigens.  

Track 3: Vaccine Types

The Vaccines type includes Recombinant Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, and Conjugate Vaccines. The Attenuated Vaccines were first developed against the viruses. The first Vaccine developed using live attenuated virus was that Rabies Vaccine. Inactivated viruses contains killed microorganisms. U.S Childhood Immunization Schedule recently recommended the Live, Attenuated Vaccines for MMR vaccine. The recombinant vaccine is developed by using the gene segment from the protein of a disease-causing organism.

Track 4: Stem Cell Immunology

The capacity of the pluri-potent stem cells is of great advantage to repair tissues, cell replacement therapeutics for treating chronic or degenerative diseases. There are chances of developing immunogenicity in response to stem cell therapy which may cause severe adverse and fatal effects to an individual. Hence various measures and strategies are being developed for the effective control of stem cell immunogenicity.

Track 5: Pediatric Immunology

About 40% of children in the world having an allergic diagnosis are due to Infectious Diseases. Paediatric Immunology mainly covers the areas about Infectious Diseases and Allergy. Child’s Immune system responds with problems when the child has allergies. Commonly the paediatrician meets the child with asthma, sinus inflammations, pneumonia, eczema and these unusual conditions called anaphylaxis. The allergy is an extreme health problem in the children. The recent advancements in paediatric immunology greatly help the General Practitioners for recognising the allergy related problems.

Track 6: Paediatric Vaccines

In recent years, the widespread of infectious diseases in children has decreased by the paediatric vaccines. The common Paediatric vaccines are Small pox Vaccine, Hepatitis B vaccine, Diphtheria Tetanus and Pertussis Vaccines, Inactivated Polio Vaccine, Measles Mumps and Rubella Vaccine. Infectious diseases were once the leading cause of death of children. Now, less number of deaths of children takes place due to the effective immunization.

Track 7: Chicken Pox Vaccines

The varicella vaccine is given for immunization against chicken pox which is a very common, contagious and fatal disease among children as it may cause serious complications. A booster shot is administered for children at 4 to 6 years of age. It is 85% effective in preventing mild illness and has a less chance of an allergic reaction with any vaccine. Getting vaccinated is the best way to prevent chickenpox

Track 8: Zika Virus Vaccines

The live-attenuated vaccine is developed to the disease caused by Zika Virus. The monovalent version of the vaccine is designed against Zika virus infection. Zika Virus belongs to the Genus Flavivirus, which is transmitted by the Aedes mosquitos.  The understanding of flavivirus particle structure, definition of E dimers as the key antigenic target, and deep understanding of neutralization mechanisms help to develop the vaccine.

Track 9: Therapeutic Cancer Vaccines

The therapeutic cancer vaccines found to have more clinical benefits in cancer treatments. Immunosuppressive cancer micro environment are the root causes of the lack of cancer eradication. The specific nature of the therapeutic cancer vaccines combines with immunomodulation which offers an attractive avenue for the development of future cancer therapies.

Track 10: Onco-Immunology

The well-known application in Cancer Immunology is Cancer Immunotherapy. Knowledge of the basic mechanisms of cancer immunology has been increasing rapidly. The current research and new findings have created these advancements in to breakthrough for many tumours. Oncologist aims to know the relationship between cancers and the normal immune system. The molecular identification of cancer antigens, Cytokine gene transfer into cancer cells, adoptive transfer of immune effector cells are some of the recent progress in cancer immunology.

Track 11: Recombinant Vaccines

The recombinant vaccine is developed through the recombinant DNA technology. These Vaccines are produced by the insertion of genetic material which encoding the antigen that stimulates an immune response. Plasmid DNA is used as vaccine which is propagated in bacteria like E.Coli and they get isolated and purified in to the vaccine.

Track 12: Flu Vaccines

Influenza is a chronic disease that leads to even death in serious conditions. About millions of people get flu every year and about tens of thousands of die from flu related diseases. Taking annual seasonal flu vaccine is the only way to decrease the risk of getting infection with seasonal flu and can spreading to other people.

Track 13: Allergy & Asthma Vaccines

The most common allergies like hay fever or house-dust mite allergy are treated using allergy vaccines. Allergy vaccines are more ejective in treating the insect stings like bee and wasp stings, which can be fatal in severe cases. The allergy vaccination is used by graduated doses begins with very small dose and it increases gradually. 

Track 14: HIV Vaccines

Currently there is no vaccine available for HIV to prevent or treatment. The long term goal is to develop safe, effective and affordable vaccines for preventing the infection in uninfected people. The difficulties faced by researchers in developing the HIV vaccines are that HIV structure changes frequently and HIV isolates are themselves highly variable.

Track 15: HPV Vaccines

The HPV vaccines like Gardasil, Gardasil 9, Cervarix were approved by the FDA. These vaccines prevent the infections with HPV types 16 and 18. The HPV types 6 and 11 are prevented by the vaccine Gardasil. The phenomenon called cross protection in which the vaccines are found to provide some protection against few additional HPV types.

Track 16: Infectious and Non infectious diseases Vaccines

More usage of Vaccines has decreased the infectious and non-infectious diseases among infants and adults. Many chronic infectious and non-infectious diseases are highly treated using the recent technologies and advanced research in monoclonal antibodies. The present challenge in vaccination world is to develop vaccines for diseases which will consistently maintain the antibody responses in human body. Some Vaccines gives immunity over life whereas some requires booster shots. However currently developing vaccines were more likely to develop the effective immunity.

Track 17: Plant Vaccines & Veterinary Vaccines

Apart from developing the vaccines from animals and microorganisms, the development of vaccine from plant also plays an important role in acting against the many chronic diseases. The implementation of several plant vaccines takes more efforts and time. The mucosal immunity and systemic immunity are highly conferred by plant made antigens through oral vaccination.

Veterinary Vaccines were proved to be beneficial for animal health. Animal diseases like Canine parvovirus, Canine distemper, Feline leukemia, Equine tetanus have been reduced more and also eliminated by the vaccines. Unfortunately, currently it is unable to make the individual vaccine program for animals to assure protection from disease and completely prevent adverse reaction.

Track 18: Transplant Immunology

The transplant immunology is more about the rejections that takes place during the transplantations. It is the study of immunologic reaction of a recipient due to transplanted organs or tissues from a histo-incompatible recipient. The immune response depends on the presence of antigens in the grafted tissue. If these antigens are absent in the recipient it is recognized as foreign substance.

The transplant rejection can be reduced by taking the immunosuppressive drugs before and after transplantation and checking the match between the donor and recipients. The transplant rejection is the response of the adaptive immune system by both cellular immunity and humoral immunity.

Track 19: Clinical Immunology & Immunopathology

Clinical immunology is the study of diseases caused by disorders of the immune system (failure, aberrant action, and malignant growth of the cellular elements of the system). It likewise includes infections of different frameworks, where safe responses have an influence in the pathology and clinical highlights.

Other immune system disorders include various hypersensitivities (such as in asthma and other allergies) that respond inappropriately to otherwise harmless compounds.

The most well-known disease that affects the immune system itself is AIDS, an immunodeficiency characterized by the suppression of CD4+ ("helper") T cells, dendritic cells and macrophages by the Human Immunodeficiency Virus (HIV).

Clinical immunologists are examining approaches to keep the resistant framework's endeavors to annihilate allografts (transplant rejections).

Track 20: Antibodies Research

Antibody also known as immunoglobulin which is a large molecule synthesized by the plasma cells and they are utilized by the immune system to neutralize the antigens. The binding mechanism of the antibody can tag the microbe or the infected cell for attacking by the other parts of the immune system. The humoral immune system mainly functions by producing the antibodies.

Track 21: Travel & Edible Vaccinations

Vaccination before travel is imperative to ensure global public health and to help individuals stay healthy during and after their travels. As such, Passport Health is committed to ensuring maximum immunization coverage in all populations from children, to members of the workforce, to the elderly, to international travelers via our nationwide clinic network.

Travel antibodies are prescribed to protect travelers from serious diseases. Contingent upon where you travel, you may come into contact with infections that are uncommon, similar to yellow fever. A few immunizations may likewise be required for you to travel to certain places. They are proposed to ensure explorers and to avert infection spread inside and between nations.

Eatable antibodies hold incredible guarantee as a financially savvy, simple to-direct, simple to-store, safeguard and sociocultural promptly adequate immunization conveyance framework, particularly for the poor creating nations. It includes presentation of chose wanted qualities into plants and after that actuating these changed plants to fabricate the encoded proteins.

Getting vaccinated will help keep you safe and healthy while you're voyaging. It will likewise help ensure that you don't convey any rare diseases home to your family, companions, and network

Track 22: Immune System Disorders

The immune system is the complex networking of cells, tissues and organs that helps us to fight against the germs. The most common immune disorders are allergy and asthma. The characterization of the immune system could be done with the help of the components of the immune system getting affected, overactive or underactive of the immune system.

Track 23: Vaccines Efficacy and Safety

In last two centuries, Vaccines plays an important role in providing the safe and effective means of preventing a number of diseases. But the safety of some vaccines has been doubted in recent years. But comparing to the infection of the diseases the vaccines are million times safer than them. New systems were developed for the production of the vaccines.

Track 24: Immunization Challenges

Vaccination efforts is challenging for 35 lower-middle countries. Nearly 24 million unimmunized or incompletely-immunized children are living in the poorest countries. Loss of public confidence because of real or spurious links to adverse events halt immunization activities in both developed and industrialized countries.

Track 25: Vaccines and Immunology Advancements

The recent advancements in vaccines protect the people from the wide variety of diseases. The main ability of the vaccines is to induce the humoral antibody responses and cell mediated responses against the wide range of pathogens. Additionally the invention can be used to produce the vaccines, immunogens and valuable therapeutic and diagnostic reagents.  

Track 26: Vaccine Induced Immunity

Vaccine induced immunity is the artificial induction of immunity to specific diseases by making the people immune to disease by means other than waiting for them to catch the infection. Vaccine induced immunity has been assessed for various infections which also includes HIV-1. The incidence of HIV infection higher in vaccine treated than in placebo-treated men with pre-existing adenovirus sterotype 5 immunity.

-----------------------------------------------------------------------------------------------------------------------------------

SUMMARY

International Congress on Vaccines & Immunology is recognized internationally and it mainly focuses on exchange of ideas all over the world.

The conference will include seminars, Oral presentations, Poster presentations, Symposiums, Workshops which will be a great platform for all the academic Researchers and Scientists to exchange their Innovations and Technology. 

The main aim of the conference is to focus on new Therapeutic technologies and recent advancements of Vaccines and Immunology.

Our Organization works on 1000+ Global Events inclusive of 350+ Conferences, 550+ upcoming and Previous Symposiums and workshops across Europe, USA and Asia from the supports of scientists and societies and Publishes 700 + Open Accessing Journals containing about 1 lakh famous identities, eminent scientists and researchers.

IMPORTANCE & SCOPE:

Vaccination belongs to important and effective ways of infectious diseases prevention. Vaccines and Immunizations are considered as a few measures for public health and safety. It is said that diseases such as diphtheria, polio, small pox etc., are becoming rare due to vaccinations and thus they help not only in providing individual protection but also community protection by preventing the spread of diseases within the population. It is believed that vaccines are the most cost-effective medication for people as it not only save lives but also greatly reduces spending on future healthcare. Vaccination is considered as the cutting edge marvel for the public health thus improving the quality of life. Many examples stand out for vaccinations being a life savior and eradicating serious effects of diseases. There will be many more potentially lifesaving vaccines in the years to come. Research is thriving, with more than 150 new vaccines currently being tested.

The initiatives being taken by the governmental organizations for vaccinations awareness programs is bringing issues to light about vaccinations and the immunizations that need to be taken amid childhood days, adolescence and for the senior people.

MARKET ANALYSIS

The vaccines market was USD 34.30 Billion in 2017, at a CAGR of 7.5% and is expected to reach USD 114.2 Billion by 2028. The CAGR for the Global Vaccines Sales market from 2018-2028 is expected to be 10.9%.

The vaccine market has a growth due to increase in prevalence in diseases, increase in government, non-government and industrial funding.

The prospective signifies a major growth in the vaccine market but due to high costs associated with the vaccine development the market growth may be retarded.

Vaccines market provides all the inclusive details of the global market, particularly in North America, Europe, Asia Pacific, Middle East and Africa and Latin America. The CAGR is expected to be the highest in the North American region followed by Asia Pacific and Europe is accounted to be the third largest market, over the forecast period.

PHARMAC announced the approval of an agreement to fund the Zoster vaccine (Zostavax) from 1st April 2018.

People who meet the funding criteria can receive their zoster vaccine at the same time as their annual influenza vaccine.

INFLUVAC® TETRA (Mylan) is the funded influenza vaccine for adults and children aged 3 years or older.

FLUARIX® TETRA (GSK) is the funded influenza vaccine for children aged less than 3 years, i.e. aged 6–35 months.

The vaccine market is highly competitive with several big and small players. The key players in the market include Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions, Inc. (U.S.), GlaxoSmithKline, plc (U.K.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Merck & Co., Inc. (U.S.), Pfizer, Inc. (U.S.), Sanofi Pasteur SA (France), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo (Japan), Protein Sciences Corporation (U.S) and Panacea Biotech (India).

The National Immunization Program of Australia aims to increase national immunization rates by funding free vaccination programs and communicating information about immunization to the general public and health professionals.

As they make an effort to control the medicinal services use, governments have been attempting persistent endeavors to diminish cost of patient inoculation through different immunization programs subsidized by government and private health authorities. The Vaccines for Children Program, for example, gives antibodies to children who need medical coverage or who can't bear the cost of the cost of inoculation. Financing is given through the Centers to Medicare and Medicaid Services (CMS) to the Centers for Disease Control (CDC) and endorsed by the Office of Management and Budget.

Ascend in take-up of new antibodies has prompted an expansion in worldwide immunization scope. As indicated by WHO, inoculation counteracts around 3 million deaths worldwide consistently, and an extra 1.5 million deaths could be maintained a strategic distance from if immunization scope progresses. As per a report discharged in 2015 by the Centers for Disease Control and Prevention (CDC), inoculation was assessed to anticipate around 21 million hospitalizations, 322 million ailments, and 732,000 deaths in kids conceived in the vicinity of 1994 and 2013, which could spare around USD 1.4 trillion in societal expenses. By 2016, DTP antibody scope had come to roughly 90% in more than 130 nations around the world.

As these areas grow both in their need and the ability and willingness of the healthcare systems to pay, further growth in vaccine sales is expected. These emerging markets are just one factor in the overall vaccine sales growth expected, but it is a significant one.

Target Audience:

Academia - 40%

Industry   –   35%

Association and societies - 15%

Other Health care Professionals -10%

• Immunologists
• Vaccinologists
• Vaccine Developers and Investigators
• Vaccine & Immunology Emeritus Professors
• Immunology Researchers
• Vaccine & Immunology Scientists
• Vaccine & Immunology Professors
• Chairmen, CEOs, Presidents, Vive-presidents, Directors, Deans, Research Scholars
• Medical faculty & staff
• Clinical Microbiologists
• Associations and Societies related to Vaccine R&D
• Immunology societies & Associations
• Vaccines Training Institutes
• Medical Devices Companies
• Vaccine Manufacturing Companies
• Clinical Data Management Companies
• Medical Equipment Companies

Major associations around the Globe for Vaccine and Immunology Research

• European Federation for Immuno-genetics
• European Society for Immunodeficiency
• American Association of Immunologists
• American Association of Veterinary Immunologists
• Australasian Society for Immunology
• British Society for Allergy and Clinical Immunology
• British Society for Immunology
• Society for Mucosal Immunology
• International Society of Travel Medicine
• The International Society of Neuro-immunology
• The International Union of Immunological Societies
• The Society for Travel Immunology
• The Society for Leukocyte Biology
• Transplantation Society
• British Society for Immunology
• Cell Death Society
• European Federation of Immunological Societies
• European Society of Gene Therapy
• Federation of African Immunological Societies
• Federation of American Societies for Experimental Biology
• Federation of Clinical Immunology Societies
• Immune Deficiency Foundation
• Infectious Diseases Society of America

Companies Associated with Vaccines Research and Production

• CareDx
• Atara
• Activartis         
• AFFiRiS          
• Hookipa Biotech Vienna,
• s-TARget Therapeutics
• Themis Bioscience       
• Valneva
• Biotherapeutics
• Benitec Limited
• InterMune
• Biotron Limited
• BioDiem
• Antisense Therapeutics Limited      
• GlaxoSmithKline USA Pty Ltd
• Bionomics
• USAn Pharmaceutical Industries (API)  
• BioPharmica Limited

Hospitals Associated with Vaccine Research and development

• Johns Hopkins Hospital Baltimore U.S
• Chris Hani Baragwanath Hospital Johannesburg South Africa
• Stanford Hospitals and Clinics U.S
• Great Ormond Street Hospital London UK
• University of Texas MD Anderson Cancer Centre Houston U.S
• Harvard Medical School Boston U.S
• Karolinska Hospital, Stockholm, Sweden
• The Priory UK
• Bumrungrad International Hospital Bangkok Thailand
• Cedars-Sinai Medical Center Los Angeles U.S

-----------------------------------------------------------------------------------------------------------------------------------

Planning a Trip to Amsterdam?? Attend our Meeting!!!

Issue with VISA!!

Vaccines Research 2018 Committee will be glad to help you in all regards to plan your trip to Amsterdam, Netherlands.  Avail the official invitation letter from us to attend this event and ahead with a closer step for approval of your VISA

Mail to:  vaccines.research@yandex.com

Experience Christmas in this magical city:

• Experience the globally renowned World Christmas Circus

• Enjoy the Amsterdam light festival where the streets and dams are decorated with many lights amidst more than 35 artworks and installations from national & international artists.

• Take pleasure of the big Christmas tree on the Dam Square, ice rink & winter market at Museumplein to explore the booths out there and the flower market at Christmas Palace.

Essential City Attractions:

• Anne Frank House

• Rijksmuseum

• Van Gogh Museum

• Heineken Experience

• Van Gogh Museum

• Amsterdam Dutch Wine and Cheese Candlelight Cruise

• Guided Amsterdam Evening Canal Cruise Including Wine and Cheese

• Amsterdam Canal Cocktail Cruise

• Zaanse Schans Windmills, Marken and Volendam Half-Day Trip from Amsterdam

• Dutch Windmills and Countryside Day Trip from Amsterdam Including Cheese Tasting in Volendam

• Bruges Day Trip from Amsterdam

• Toms Travel Tours

• We Bike Amsterdam Tours

• Joy Ride Tours

• Amsterdam en Bicicleta

• Sarah's Tours

• Wetlands Safari

• Wheely Dutch Bike Tours - Day Tours

• LimoBike

• Lowlands Tours

• Flagship Amsterdam

• Romantic Tour Amsterdam

• Amsterdam Jewel Cruises - Dinner Cruise and many more...

NOTE: The invitation letter will be provided after the attendee confirms his/her participation by reserving their delegate/ speaker slot for the conference.

-----------------------------------------------------------------------------------------------------------------------------------

PRESENTATION REQUIREMENTS:

• Presenting authors are responsible for registration, travel, and hotel costs. Note: Those with accepted abstracts will receive an acceptance mail allowing them to register for the conference.

• Abstracts will be compiled and conference books are made available to participants at the conference.

• Any presenter who is unable to attend should arrange for another qualified individual to present the paper/poster in question. If such a change is necessary, please notify our conference team

SUBMISSION OPTIONS:

• Oral paper presentations will have 30-minute time slots and be clustered by theme into sessions. The keynote session will have for 45-minute time slot, workshop/ special session will have 60-minute time slot and symposium will have 60-minute time slot followed by 5-minute Q&A session.

• Graduate & Masters students are eligible to submit their abstracts under poster and e-poster presentation category.

• Ph.D. students are eligible to submit their abstract under special YRF (young researcher’s forum), poster and e-poster presentation category. NOTE: YRF category includes short oral presentation specially for Ph. D. students

• Extended abstract: Submissions should utilize the Abstract Template. Papers submitted in this category may represent original empirical research, theoretical development, reviews, or critiques.

-----------------------------------------------------------------------------------------------------------------------------------

Early Bird Abstract Submission: August 29, 2018

Second Line Abstract Submission: September 26, 2018

Abstract Submission Deadline: November 02, 2018

-----------------------------------------------------------------------------------------------------------------------------------

The 15^th Annual Summit on Vaccines and Immunization (Vaccines Summit 2017) hosted by Conference Series LLC took place at Berlin, Germany during February 20-21, 2017. It was organized by Conference Series llc Ltd and generous response was received from the Editorial Board Members as well as from eminent scientists, talented researchers and young student community.

Researchers and students who attended from different parts of the world made the conference one of the most successful and productive events in 2017 from Conference Series LLC Ltd.

The two day program witnessed thought provoking keynote and plenary presentations from experts in the field of Vaccines and Immunization, highlighting the theme “Discussion on Novel research technologies and practical challenges in Vaccination".

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

• Bacterial and Viral Vaccines
• Vaccines Against infectious diseases
• Cancer Vaccines
• DNA, Protein and Toxoid Vaccines
• Combination and Conjugate Vaccines
• Travel and Edible vaccines
• Malaria and TB Vaccines
• Hepatitis, HIV and STD Vaccines
• Pediatric Vaccination
• Vaccines for Immune mediated Diseases
• Vaccination for Emerging and Re-emerging diseases
• Vaccine production and delivery technologies
• Vaccine Safety and Efficacy
• Vaccines Industry & Manufacturing
• Geriatric Immunization
• Vaccines for unconventional diseases
• Animal and Plant Derived Vaccines
• Vaccines for Pregnant women and Neonates
• Animal Models and Clinical Trials
• Cellular Immunology and Latest Innovations
• Clinical Immunology & Cancer Immunotherapy
• Molecular and Structural Immunology
• Antibodies : Engineering and Therapeutics

The highlights of the meeting were the eponymic keynote lectures from

• Giulio Tarro, Foundation de Beaumont Bonelli for Cancer Research, Italy
• Francis Eko, Morehouse School of Medicine, USA
• Lallan Giri, Biologics Resources LLC, USA
• Yusuf Omosun, Morehouse School of Medicine, USA
• Imran Saleem, Liverpool John Moores University, UK
• Gustavo Cabral de Miranda, University of Oxford, UK

Vaccines Summit 2017 played an important role in promoting multidisciplinary interactions between Science and Medicine to enhance research in Vaccines and Immunization. The program covered current and emerging research innovations in the field of Vaccines and Immunology.

We would specially thank the Moderator of the Giulio Tarro, Foundation de Beaumont Bonelli for Cancer Research, Italy, for his contribution for the conference.

We are obliged to the various delegates from companies and institutes who actively took part in the discussions. We sincerely thank the Organizing Committee Members and Editorial board of Vaccines Summit 2017 for their gracious presence and continuous support throughout the proceedings of this event. With the valuable feedback and generous response received from the participants of the event, Conference Series LLC would like to announce the commencement of “International Congress on Vaccines and Immunology" on December 06-07, 2018 at Amsterdam, Netherlands.

Let us meet again @ Vaccines Research 2018